Stimulation in vivo of expression of intra-abdominal adipose tissue plasminogen activator inhibitor Type I by proinsulinNORDT, T. K; BODE, C; SOBEL, B. E et al.Diabetologia (Berlin). 2001, Vol 44, Num 9, pp 1121-1124, issn 0012-186XArticle

Differential regulation by troglitazone of plasminogen activator inhibitor type 1 in human hepatic and vascular cellsNORDT, T. K; PETER, K; BODE, C et al.The Journal of clinical endocrinology and metabolism. 2000, Vol 85, Num 4, pp 1563-1568, issn 0021-972XArticle

Augmentation of the synthesis of plasminogen activator inhibitor type-1 by precursors of insulin : a potential risk factor for vascular diseaseNORDT, T. K; SCHNEIDER, D. J; SOBEL, B. E et al.Circulation (New York, N.Y.). 1994, Vol 89, Num 1, pp 321-330, issn 0009-7322Article

Stimulation by proinsulin of expression of plasminogen activator inhibitor type-I in endothelial cellsSCHNEIDER, D. J; NORDT, T. K; SOBEL, B. E et al.Diabetes (New York, NY). 1992, Vol 41, Num 7, pp 890-895, issn 0012-1797Article

Influence of breakfasts with different nutrient contents on glucose, C peptide, insulin, glucagon, triglycerides, and GIP in non-insulin-dependent diabeticsNORDT, T. K; BESENTHAL, I; EGGSTEIN, M et al.The American journal of clinical nutrition. 1991, Vol 53, Num 1, pp 155-160, issn 0002-9165, 6 p.Article

Attenuated fibrinolysis and accelerated atherogenesis in type II diabetic patientsSCHNEIDER, D. J; NORDT, T. K; SOBEL, B. E et al.Diabetes (New York, NY). 1993, Vol 42, Num 1, pp 1-7, issn 0012-1797Article

Elaboration of type-1 plasminogen activator inhibitor from adipocytes : a potential pathogenetic link between obesity and cardiovascular diseaseLUNDGREN, C. H; BROWN, S. L; NORDT, T. K et al.Circulation (New York, N.Y.). 1996, Vol 93, Num 1, pp 106-110, issn 0009-7322Article

Augmented platelet aggregation as predictor of reocclusion after thrombolysis in acute myocardial infarctionNORDT, T. K; MOSER, M; KOHLER, B et al.Thrombosis and haemostasis. 1998, Vol 80, Num 6, pp 881-886, issn 0340-6245Article

Patency trials with reteplase (r-PA) : What do they tell us ?BODE, C; NORDT, T. K; PETER, K et al.The American journal of cardiology. 1996, Vol 78, Num 12A, pp 16-19, issn 0002-9149Conference Paper

A bispecific antifibrin-antiplatelet urokinase conjugate (BAAUC) induces enhanced clot lysis and inhibits platelet aggregationRUEF, J; NORDT, T. K; PETER, K et al.Thrombosis and haemostasis. 1999, Vol 82, Num 1, pp 109-114, issn 0340-6245Article

Attenuation by gemfibrozil of expression of plasminogen activator inhibitor type 1 induced by Insulin and its precursorsNORDT, T. K; KORNAS, K; PETER, K et al.Circulation (New York, N.Y.). 1997, Vol 95, Num 3, pp 677-683, issn 0009-7322Article

Induction of plasminogen activator inhibitor type-1 (PAI-1) by proinsulin and insulin in vivoNORDT, T. K; SAWA, H; FUJII, S et al.Circulation (New York, N.Y.). 1995, Vol 91, Num 3, pp 764-770, issn 0009-7322Conference Paper

Augmentation of synthesis of plasminogen activator inhibitor type-1 in arterial endothelial cells by glucose and its implications for local fibrinolysisNORDT, T. K; KLASSEN, K. J; SCHNEIDER, D. J et al.Arteriosclerosis and thrombosis. 1993, Vol 13, Num 12, pp 1822-1828, issn 1049-8834Article